449 related articles for article (PubMed ID: 17675517)
1. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.
Chackerian AA; Oldham ER; Murphy EE; Schmitz J; Pflanz S; Kastelein RA
J Immunol; 2007 Aug; 179(4):2551-5. PubMed ID: 17675517
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory function of Fc-ST2 depends on cell type; IL-1RAcP and ST2 are necessary but insufficient for IL-33 activity.
Hong K; Lee Y; Lee S; Hong S; Bae S; Hong J; Choi J; Jhun H; Kwak A; Kim E; Jo S; Kang T; Cho YS; Kim YG; Kim S
Immunol Res; 2013 May; 56(1):122-30. PubMed ID: 23435764
[TBL] [Abstract][Full Text] [Related]
3. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.
Moulin D; Donzé O; Talabot-Ayer D; Mézin F; Palmer G; Gabay C
Cytokine; 2007 Dec; 40(3):216-25. PubMed ID: 18023358
[TBL] [Abstract][Full Text] [Related]
4. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
Schmitz J; Owyang A; Oldham E; Song Y; Murphy E; McClanahan TK; Zurawski G; Moshrefi M; Qin J; Li X; Gorman DM; Bazan JF; Kastelein RA
Immunity; 2005 Nov; 23(5):479-90. PubMed ID: 16286016
[TBL] [Abstract][Full Text] [Related]
5. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
Palmer G; Lipsky BP; Smithgall MD; Meininger D; Siu S; Talabot-Ayer D; Gabay C; Smith DE
Cytokine; 2008 Jun; 42(3):358-64. PubMed ID: 18450470
[TBL] [Abstract][Full Text] [Related]
6. The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders.
Saluja R; Ketelaar ME; Hawro T; Church MK; Maurer M; Nawijn MC
Mol Immunol; 2015 Jan; 63(1):80-5. PubMed ID: 25017307
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of ST2 (IL-1R4) specific for IL-33 activity; no suppression by IL-1Ra though a common chain IL-1R3 (IL-1RAcP) shared with IL-1.
Jo S; Kim E; Kwak A; Lee J; Hong J; Lee J; Youn S; Bae S; Kim B; Ryoo S; Kang TB; Her E; Choi DK; Kim YS; Lee Y; Jhun H; Kim S
Cytokine; 2016 Jul; 83():33-40. PubMed ID: 27031441
[TBL] [Abstract][Full Text] [Related]
8. IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection.
Zeng S; Wu J; Liu J; Qi F; Liu B
Scand J Immunol; 2015 Jun; 81(6):494-501. PubMed ID: 25721734
[TBL] [Abstract][Full Text] [Related]
9. Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared Receptor.
Fields JK; Kihn K; Birkedal GS; Klontz EH; Sjöström K; Günther S; Beadenkopf R; Forsberg G; Liberg D; Snyder GA; Deredge D; Sundberg EJ
Front Immunol; 2021; 12():779100. PubMed ID: 35003094
[TBL] [Abstract][Full Text] [Related]
10. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.
Hayakawa H; Hayakawa M; Kume A; Tominaga S
J Biol Chem; 2007 Sep; 282(36):26369-80. PubMed ID: 17623648
[TBL] [Abstract][Full Text] [Related]
11. The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.
Bulek K; Swaidani S; Qin J; Lu Y; Gulen MF; Herjan T; Min B; Kastelein RA; Aronica M; Kosz-Vnenchak M; Li X
J Immunol; 2009 Mar; 182(5):2601-9. PubMed ID: 19234154
[TBL] [Abstract][Full Text] [Related]
12. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system.
Kondo Y; Yoshimoto T; Yasuda K; Futatsugi-Yumikura S; Morimoto M; Hayashi N; Hoshino T; Fujimoto J; Nakanishi K
Int Immunol; 2008 Jun; 20(6):791-800. PubMed ID: 18448455
[TBL] [Abstract][Full Text] [Related]
13. IL-1, IL-18, and IL-33 families of cytokines.
Arend WP; Palmer G; Gabay C
Immunol Rev; 2008 Jun; 223():20-38. PubMed ID: 18613828
[TBL] [Abstract][Full Text] [Related]
14. IL-33 exacerbates antigen-induced arthritis by activating mast cells.
Xu D; Jiang HR; Kewin P; Li Y; Mu R; Fraser AR; Pitman N; Kurowska-Stolarska M; McKenzie AN; McInnes IB; Liew FY
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10913-8. PubMed ID: 18667700
[TBL] [Abstract][Full Text] [Related]
15. The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells.
Drube S; Heink S; Walter S; Löhn T; Grusser M; Gerbaulet A; Berod L; Schons J; Dudeck A; Freitag J; Grotha S; Reich D; Rudeschko O; Norgauer J; Hartmann K; Roers A; Kamradt T
Blood; 2010 May; 115(19):3899-906. PubMed ID: 20200353
[TBL] [Abstract][Full Text] [Related]
16. Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.
Lingel A; Weiss TM; Niebuhr M; Pan B; Appleton BA; Wiesmann C; Bazan JF; Fairbrother WJ
Structure; 2009 Oct; 17(10):1398-410. PubMed ID: 19836339
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into the interaction of IL-33 with its receptors.
Liu X; Hammel M; He Y; Tainer JA; Jeng US; Zhang L; Wang S; Wang X
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14918-23. PubMed ID: 23980170
[TBL] [Abstract][Full Text] [Related]
18. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.
Ali S; Huber M; Kollewe C; Bischoff SC; Falk W; Martin MU
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18660-5. PubMed ID: 18003919
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of anti-IL-1R accessory protein antibodies on IL-1alpha or IL-1beta-induced production of PGE(2) and IL-6 from 3T3-L1 cells.
Yoon DY; Dinarello CA
J Biochem Mol Biol; 2007 Jul; 40(4):562-70. PubMed ID: 17669273
[TBL] [Abstract][Full Text] [Related]
20. Characterization of ST2 transgenic mice with resistance to IL-33.
Ohto-Ozaki H; Kuroiwa K; Mato N; Matsuyama Y; Hayakawa M; Tamemoto H; Tominaga S
Eur J Immunol; 2010 Sep; 40(9):2632-42. PubMed ID: 20662097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
